ALL Rehberi
Description
Akut lenfositik lösemi (ALL) bir kan kanseri türüdür. ALL, aynı zamanda akut lenfoblastik lösemi ve akut lenfoid lösemi olarak da bilinir. Bu uygulama bilgilendirme amaçlı hazırlanmış olup, içerisinde yer alan bilgiler hekime danışmanın yerine geçmez. Daha fazla bilgi için hekiminize başvurunuz.
Screenshots
ALL Rehberi FAQ
-
Is ALL Rehberi free?
Yes, ALL Rehberi is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is ALL Rehberi legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does ALL Rehberi cost?
ALL Rehberi is free.
-
What is ALL Rehberi revenue?
To get estimated revenue of ALL Rehberi app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Romania yet.
Ratings History
ALL Rehberi Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
ALL Rehberi Installs
Last 30 days
ALL Rehberi Revenue
Last 30 daysALL Rehberi Revenue and Downloads
Gain valuable insights into ALL Rehberi performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 1.1 (2 years ago )
- Released on
- Oct 4, 2018 (6 years ago )
- Also available in
- Türkiye , Pakistan , Israel , India , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Netherlands , New Zealand , Peru , Philippines , Ireland , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Thailand , Taiwan , United States , Uzbekistan , South Africa , Germany , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , United Arab Emirates , Denmark , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , Greece , Hong Kong SAR China , Croatia , Hungary , Indonesia
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.